位置:首页 > 蛋白库 > CYSP_TRYCR
CYSP_TRYCR
ID   CYSP_TRYCR              Reviewed;         467 AA.
AC   P25779;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1992, sequence version 1.
DT   03-AUG-2022, entry version 139.
DE   RecName: Full=Cruzipain;
DE            EC=3.4.22.51;
DE   AltName: Full=Cruzaine;
DE   AltName: Full=Major cysteine proteinase;
DE   Flags: Precursor;
OS   Trypanosoma cruzi.
OC   Eukaryota; Discoba; Euglenozoa; Kinetoplastea; Metakinetoplastina;
OC   Trypanosomatida; Trypanosomatidae; Trypanosoma; Schizotrypanum.
OX   NCBI_TaxID=5693;
RN   [1]
RP   NUCLEOTIDE SEQUENCE.
RC   STRAIN=Tulahuen;
RX   PubMed=1559982; DOI=10.1016/s0021-9258(18)42533-1;
RA   Eakin A.E., Mills A.A., Harth G., McKerrow J.H., Craik C.S.;
RT   "The sequence, organization, and expression of the major cysteine protease
RT   (cruzain) from Trypanosoma cruzi.";
RL   J. Biol. Chem. 267:7411-7420(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (CLONES 1800-2 AND 1800-4).
RC   STRAIN=Tulahuen 2;
RX   PubMed=1311053; DOI=10.1016/0166-6851(92)90219-a;
RA   Campetella O., Henriksson J., Aaslund L., Frasch A.C.C., Pettersson U.,
RA   Cazzulo J.J.;
RT   "The major cysteine proteinase (cruzipain) from Trypanosoma cruzi is
RT   encoded by multiple polymorphic tandemly organized genes located on
RT   different chromosomes.";
RL   Mol. Biochem. Parasitol. 50:225-234(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 141-306.
RC   STRAIN=RA;
RX   PubMed=2406590; DOI=10.1016/0166-6851(90)90002-4;
RA   Eakin A.E., Bouvier J., Sakanari J.A., Craik C.S., McKerrow J.H.;
RT   "Amplification and sequencing of genomic DNA fragments encoding cysteine
RT   proteases from protozoan parasites.";
RL   Mol. Biochem. Parasitol. 39:1-8(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 295-467.
RC   STRAIN=Tulahuen 2;
RX   PubMed=2038364; DOI=10.1016/0166-6851(91)90103-d;
RA   Aaslund L., Henriksson J., Campetella O., Frasch A.C.C., Pettersson U.,
RA   Cazzulo J.J.;
RT   "The C-terminal extension of the major cysteine proteinase (cruzipain) from
RT   Trypanosoma cruzi.";
RL   Mol. Biochem. Parasitol. 45:345-348(1991).
RN   [5]
RP   AUTOCATALYSIS OF C-TERMINAL.
RC   STRAIN=Tulahuen 2;
RX   PubMed=2011151; DOI=10.1016/0166-6851(91)90216-s;
RA   Hellman U., Wernstedt C., Cazzulo J.J.;
RT   "Self-proteolysis of the cysteine proteinase, cruzipain, from Trypanosoma
RT   cruzi gives a major fragment corresponding to its carboxy-terminal
RT   domain.";
RL   Mol. Biochem. Parasitol. 44:15-21(1991).
RN   [6]
RP   SPECIFICITY.
RC   STRAIN=Tulahuen 2;
RX   PubMed=2407295; DOI=10.1016/0167-4838(90)90166-d;
RA   Cazzulo J.J., Cazzulo-Franke M.C., Martinez J., Franke de Cazzulo B.M.;
RT   "Some kinetic properties of a cysteine proteinase (cruzipain) from
RT   Trypanosoma cruzi.";
RL   Biochim. Biophys. Acta 1037:186-191(1990).
RN   [7]
RP   PROTEIN SEQUENCE OF 123-146 AND 304-317.
RX   PubMed=2651912; DOI=10.1016/0166-6851(89)90039-x;
RA   Cazzulo J.J., Couso R., Raimondi A., Wernstedt C., Hellman U.;
RT   "Further characterization and partial amino acid sequence of a cysteine
RT   proteinase from Trypanosoma cruzi.";
RL   Mol. Biochem. Parasitol. 33:33-42(1989).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 123-337.
RX   PubMed=9260273; DOI=10.1002/pro.5560060801;
RA   Gillmor S.A., Craik C.S., Fletterick R.J.;
RT   "Structural determinants of specificity in the cysteine protease cruzain.";
RL   Protein Sci. 6:1603-1611(1997).
CC   -!- FUNCTION: Hydrolyzes chromogenic peptides at the carboxyl Arg or Lys;
CC       requires at least one more amino acid, preferably Arg, Phe, Val or Leu,
CC       between the terminal Arg or Lys and the amino-blocking group.
CC   -!- FUNCTION: The cysteine protease may play an important role in the
CC       development and differentiation of the parasites at several stages of
CC       their life cycle.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Broad endopeptidase specificity similar to that of cathepsin
CC         L.; EC=3.4.22.51;
CC   -!- ACTIVITY REGULATION: Strongly inhibited by E-64 (L-trans-
CC       epoxysuccinylleucylamido(4-guanidino)butane), Leupeptin, and N-alpha-p-
CC       tosyl-L-lysine chloromethyl ketone.
CC   -!- DEVELOPMENTAL STAGE: Present in all developmental stages.
CC   -!- MISCELLANEOUS: Purified cruzipain is able to degrade itself, yielding a
CC       complex mixture of small peptides, and a major 25 kDa fragment.
CC   -!- SIMILARITY: Belongs to the peptidase C1 family. {ECO:0000255|PROSITE-
CC       ProRule:PRU10088, ECO:0000255|PROSITE-ProRule:PRU10089,
CC       ECO:0000255|PROSITE-ProRule:PRU10090}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M84342; AAA30181.1; -; Genomic_DNA.
DR   EMBL; M69121; AAA30269.1; -; Genomic_DNA.
DR   EMBL; M69121; AAA30270.1; -; Genomic_DNA.
DR   EMBL; X54414; CAA38278.1; -; mRNA.
DR   EMBL; M27305; AAA30180.1; -; Genomic_DNA.
DR   PIR; A60667; A60667.
DR   PIR; S16162; S16162.
DR   PDB; 1AIM; X-ray; 2.00 A; A=123-337.
DR   PDB; 1EWL; X-ray; 2.00 A; A=123-337.
DR   PDB; 1EWM; X-ray; 2.00 A; A=123-337.
DR   PDB; 1EWO; X-ray; 2.10 A; A=123-337.
DR   PDB; 1EWP; X-ray; 1.75 A; A=123-337.
DR   PDB; 1F29; X-ray; 2.15 A; A/B/C=123-337.
DR   PDB; 1F2A; X-ray; 1.60 A; A=123-337.
DR   PDB; 1F2B; X-ray; 1.80 A; A=123-337.
DR   PDB; 1F2C; X-ray; 2.00 A; A=123-337.
DR   PDB; 1ME3; X-ray; 1.20 A; A=123-337.
DR   PDB; 1ME4; X-ray; 1.20 A; A=123-337.
DR   PDB; 1U9Q; X-ray; 2.30 A; X=123-337.
DR   PDB; 2AIM; X-ray; 2.20 A; A=123-337.
DR   PDB; 2OZ2; X-ray; 1.95 A; A/C=123-337.
DR   PDB; 3HD3; X-ray; 1.75 A; A/B=123-337.
DR   PDB; 3I06; X-ray; 1.10 A; A=123-337.
DR   PDB; 3IUT; X-ray; 1.20 A; A=123-337.
DR   PDB; 3KKU; X-ray; 1.28 A; A=123-337.
DR   PDB; 3LXS; X-ray; 1.50 A; A/C=123-337.
DR   PDB; 4KLB; X-ray; 2.62 A; A/B/C/D/E=123-337.
DR   PDB; 4PI3; X-ray; 1.27 A; A/B=122-337.
DR   PDB; 4QH6; X-ray; 3.13 A; A/B/C/D/E=123-337.
DR   PDB; 4W5B; X-ray; 2.70 A; A/B/C=123-337.
DR   PDB; 4W5C; X-ray; 3.27 A; A/B/C/D/E=122-337.
DR   PDB; 4XUI; X-ray; 2.51 A; A/B/C=122-337.
DR   PDB; 6N3S; X-ray; 1.19 A; A/B=123-337.
DR   PDB; 6O2X; X-ray; 1.19 A; A/B=123-337.
DR   PDB; 6UX6; X-ray; 1.94 A; A=123-337.
DR   PDB; 7JUJ; X-ray; 2.20 A; A/B/C/D/E/F=123-337.
DR   PDB; 7S18; X-ray; 2.14 A; A=123-337.
DR   PDB; 7S19; X-ray; 2.08 A; A=123-337.
DR   PDBsum; 1AIM; -.
DR   PDBsum; 1EWL; -.
DR   PDBsum; 1EWM; -.
DR   PDBsum; 1EWO; -.
DR   PDBsum; 1EWP; -.
DR   PDBsum; 1F29; -.
DR   PDBsum; 1F2A; -.
DR   PDBsum; 1F2B; -.
DR   PDBsum; 1F2C; -.
DR   PDBsum; 1ME3; -.
DR   PDBsum; 1ME4; -.
DR   PDBsum; 1U9Q; -.
DR   PDBsum; 2AIM; -.
DR   PDBsum; 2OZ2; -.
DR   PDBsum; 3HD3; -.
DR   PDBsum; 3I06; -.
DR   PDBsum; 3IUT; -.
DR   PDBsum; 3KKU; -.
DR   PDBsum; 3LXS; -.
DR   PDBsum; 4KLB; -.
DR   PDBsum; 4PI3; -.
DR   PDBsum; 4QH6; -.
DR   PDBsum; 4W5B; -.
DR   PDBsum; 4W5C; -.
DR   PDBsum; 4XUI; -.
DR   PDBsum; 6N3S; -.
DR   PDBsum; 6O2X; -.
DR   PDBsum; 6UX6; -.
DR   PDBsum; 7JUJ; -.
DR   PDBsum; 7S18; -.
DR   PDBsum; 7S19; -.
DR   AlphaFoldDB; P25779; -.
DR   BMRB; P25779; -.
DR   SMR; P25779; -.
DR   BindingDB; P25779; -.
DR   ChEMBL; CHEMBL3563; -.
DR   DrugBank; DB02200; 3-[N-[benzyloxycarbonyl]-phenylalaninyl-amino]-5-phenyl-pentane-1-sulfonylmethylbenzene.
DR   DrugBank; DB04427; 4-Methyl-N-[(2S)-1-oxo-3-phenyl-1-[[(3S)-1-phenyl-5-(phenylmethoxysulfamoyl)pentan-3-yl]amino]propan-2-yl]piperazine-1-carboxamide.
DR   DrugBank; DB02051; 4-Nitrophenyl (3S)-3-({N-[(benzyloxy)carbonyl]-L-phenylalanyl}amino)-5-phenyl-1-pentanesulfonate.
DR   DrugBank; DB01871; [1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester.
DR   DrugBank; DB01810; [1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester.
DR   DrugBank; DB02128; [1-(3-hydroxy-2-oxo-1-phenethyl-propylcarbamoyl)2-phenyl-ethyl]-carbamic acid pyridin-4-ylmethyl ester.
DR   DrugBank; DB03536; Benzyl N-[(2S)-5-(diaminomethylamino)-1-[[(2S)-4-fluoro-3-oxobutan-2-yl]amino]-1-oxopentan-2-yl]carbamate.
DR   DrugBank; DB03691; WRR-112.
DR   DrugBank; DB04502; WRR-204.
DR   DrugBank; DB03573; WRR-99.
DR   DrugCentral; P25779; -.
DR   MEROPS; C01.075; -.
DR   VEuPathDB; TriTrypDB:BCY84_22436; -.
DR   VEuPathDB; TriTrypDB:C3747_50g3; -.
DR   VEuPathDB; TriTrypDB:C3747_50g6; -.
DR   VEuPathDB; TriTrypDB:C3747_50g7; -.
DR   VEuPathDB; TriTrypDB:C4B63_89g68; -.
DR   VEuPathDB; TriTrypDB:Tc_MARK_8050; -.
DR   VEuPathDB; TriTrypDB:Tc_MARK_8695; -.
DR   VEuPathDB; TriTrypDB:TcBrA4_0068180; -.
DR   VEuPathDB; TriTrypDB:TcCL_NonESM02572; -.
DR   VEuPathDB; TriTrypDB:TcCLB.507603.260; -.
DR   VEuPathDB; TriTrypDB:TcCLB.509429.320; -.
DR   VEuPathDB; TriTrypDB:TCDM_05847; -.
DR   VEuPathDB; TriTrypDB:TcG_06121; -.
DR   VEuPathDB; TriTrypDB:TCSYLVIO_008967; -.
DR   VEuPathDB; TriTrypDB:TcYC6_0061420; -.
DR   VEuPathDB; TriTrypDB:TcYC6_0061430; -.
DR   VEuPathDB; TriTrypDB:TcYC6_0061460; -.
DR   VEuPathDB; TriTrypDB:TcYC6_0061470; -.
DR   BRENDA; 3.4.22.51; 6524.
DR   SABIO-RK; P25779; -.
DR   EvolutionaryTrace; P25779; -.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   CDD; cd02248; Peptidase_C1A; 1.
DR   InterPro; IPR021981; DUF3586.
DR   InterPro; IPR038765; Papain-like_cys_pep_sf.
DR   InterPro; IPR025661; Pept_asp_AS.
DR   InterPro; IPR000169; Pept_cys_AS.
DR   InterPro; IPR025660; Pept_his_AS.
DR   InterPro; IPR000668; Peptidase_C1A_C.
DR   InterPro; IPR039417; Peptidase_C1A_papain-like.
DR   InterPro; IPR013201; Prot_inhib_I29.
DR   Pfam; PF12131; DUF3586; 1.
DR   Pfam; PF08246; Inhibitor_I29; 1.
DR   Pfam; PF00112; Peptidase_C1; 1.
DR   PRINTS; PR00705; PAPAIN.
DR   SMART; SM00848; Inhibitor_I29; 1.
DR   SMART; SM00645; Pept_C1; 1.
DR   SUPFAM; SSF54001; SSF54001; 1.
DR   PROSITE; PS00640; THIOL_PROTEASE_ASN; 1.
DR   PROSITE; PS00139; THIOL_PROTEASE_CYS; 1.
DR   PROSITE; PS00639; THIOL_PROTEASE_HIS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Autocatalytic cleavage; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Hydrolase; Protease; Signal; Thiol protease;
KW   Zymogen.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000305"
FT   PROPEP          19..122
FT                   /note="Activation peptide"
FT                   /evidence="ECO:0000305|PubMed:2651912"
FT                   /id="PRO_0000026372"
FT   CHAIN           123..467
FT                   /note="Cruzipain"
FT                   /id="PRO_0000026373"
FT   REGION          333..355
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        147
FT   ACT_SITE        284
FT   ACT_SITE        304
FT   SITE            337..338
FT                   /note="Cleavage; by autolysis"
FT                   /evidence="ECO:0000269|PubMed:1559982"
FT   CARBOHYD        169
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        292
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        377
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        144..185
FT   DISULFID        178..223
FT   DISULFID        277..325
FT   VARIANT         9
FT                   /note="L -> S (in clone 1800-2)"
FT   VARIANT         35
FT                   /note="T -> A (in clone 1800-2)"
FT   VARIANT         39
FT                   /note="A -> V (in clone 1800-2)"
FT   VARIANT         51
FT                   /note="S -> N (in clone 1800-4)"
FT   VARIANT         56
FT                   /note="A -> R (in clone 1800-2)"
FT   VARIANT         76
FT                   /note="N -> G (in clone 1800-4)"
FT   VARIANT         109
FT                   /note="Q -> G (in clone 1800-4)"
FT   VARIANT         117
FT                   /note="K -> N (in clone 1800-2)"
FT   VARIANT         146
FT                   /note="S -> G"
FT   VARIANT         157..158
FT                   /note="EC -> SG (in strain: RA)"
FT   VARIANT         186
FT                   /note="S -> G (in clones 1800-2 and 1800-4)"
FT   VARIANT         204
FT                   /note="A -> G (in strain: RA)"
FT   VARIANT         250..251
FT                   /note="WL -> CV (in clones 1800-2 and 1800-4)"
FT   VARIANT         261..262
FT                   /note="VD -> H (in strain: RA)"
FT   VARIANT         286
FT                   /note="V -> F (in clone 1800-4)"
FT   VARIANT         286
FT                   /note="V -> L (in strain: RA)"
FT   VARIANT         308
FT                   /note="T -> A (in clone 1800-2)"
FT   VARIANT         313
FT                   /note="E -> D"
FT   VARIANT         409
FT                   /note="L -> F (in clone 1800-2)"
FT   VARIANT         427
FT                   /note="K -> Q (in clone 1800-2)"
FT   VARIANT         430
FT                   /note="R -> W (in clone 1800-2)"
FT   VARIANT         457
FT                   /note="H -> Y (in clone 1800-2)"
FT   VARIANT         461
FT                   /note="H -> Q (in clone 1800-2)"
FT   CONFLICT        357
FT                   /note="S -> C (in Ref. 4)"
FT                   /evidence="ECO:0000305"
FT   STRAND          125..128
FT                   /evidence="ECO:0007829|PDB:3I06"
FT   HELIX           129..132
FT                   /evidence="ECO:0007829|PDB:3I06"
FT   STRAND          143..145
FT                   /evidence="ECO:0007829|PDB:6UX6"
FT   HELIX           147..162
FT                   /evidence="ECO:0007829|PDB:3I06"
FT   HELIX           172..178
FT                   /evidence="ECO:0007829|PDB:3I06"
FT   STRAND          180..182
FT                   /evidence="ECO:0007829|PDB:3I06"
FT   HELIX           184..186
FT                   /evidence="ECO:0007829|PDB:3I06"
FT   HELIX           190..200
FT                   /evidence="ECO:0007829|PDB:3I06"
FT   STRAND          204..207
FT                   /evidence="ECO:0007829|PDB:3I06"
FT   TURN            208..210
FT                   /evidence="ECO:0007829|PDB:3I06"
FT   STRAND          216..218
FT                   /evidence="ECO:0007829|PDB:2AIM"
FT   STRAND          225..227
FT                   /evidence="ECO:0007829|PDB:1F2A"
FT   STRAND          230..239
FT                   /evidence="ECO:0007829|PDB:3I06"
FT   HELIX           244..254
FT                   /evidence="ECO:0007829|PDB:3I06"
FT   STRAND          257..261
FT                   /evidence="ECO:0007829|PDB:3I06"
FT   HELIX           263..265
FT                   /evidence="ECO:0007829|PDB:4QH6"
FT   HELIX           266..268
FT                   /evidence="ECO:0007829|PDB:3I06"
FT   STRAND          271..274
FT                   /evidence="ECO:0007829|PDB:3I06"
FT   STRAND          284..297
FT                   /evidence="ECO:0007829|PDB:3I06"
FT   STRAND          299..303
FT                   /evidence="ECO:0007829|PDB:3I06"
FT   TURN            307..309
FT                   /evidence="ECO:0007829|PDB:7JUJ"
FT   STRAND          315..322
FT                   /evidence="ECO:0007829|PDB:3I06"
FT   HELIX           324..326
FT                   /evidence="ECO:0007829|PDB:3I06"
FT   STRAND          329..336
FT                   /evidence="ECO:0007829|PDB:3I06"
SQ   SEQUENCE   467 AA;  49836 MW;  B93EBA49B511363D CRC64;
     MSGWARALLL AAVLVVMACL VPAATASLHA EETLTSQFAE FKQKHGRVYE SAAEEAFRLS
     VFRENLFLAR LHAAANPHAT FGVTPFSDLT REEFRSRYHN GAAHFAAAQE RARVPVKVEV
     VGAPAAVDWR ARGAVTAVKD QGQCGSCWAF SAIGNVECQW FLAGHPLTNL SEQMLVSCDK
     TDSGCSGGLM NNAFEWIVQE NNGAVYTEDS YPYASGEGIS PPCTTSGHTV GATITGHVEL
     PQDEAQIAAW LAVNGPVAVA VDASSWMTYT GGVMTSCVSE QLDHGVLLVG YNDSAAVPYW
     IIKNSWTTQW GEEGYIRIAK GSNQCLVKEE ASSAVVGGPG PTPEPTTTTT TSAPGPSPSY
     FVQMSCTDAA CIVGCENVTL PTGQCLLTTS GVSAIVTCGA ETLTEEVFLT STHCSGPSVR
     SSVPLNKCNR LLRGSVEFFC GSSSSGRLAD VDRQRRHQPY HSRHRRL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024